Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-viral chimeric antigen receptor (CAR) T cells going viral
Hyatt Balke‐Want, Vimal Keerthi, Amaia Cadiñanos-Garai, et al.
Immuno-Oncology Technology (2023) Vol. 18, pp. 100375-100375
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

CAR-T cell manufacturing: Major process parameters and next-generation strategies
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 73
Forks in the road for CAR T and CAR NK cell cancer therapies
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 63
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 38
Advancing Autoimmune Rheumatic Disease Treatment: CAR-T Cell Therapies - Evidence, Safety, and Future Directions
Ryunosuke Ohno, Akihiro Nakamura
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152479-152479
Open Access | Times Cited: 13
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells
Dong Hu, Ruyue Yang, Guidan Wang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2773-2791
Open Access | Times Cited: 11
The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd, et al.
Life Sciences (2024) Vol. 348, pp. 122683-122683
Closed Access | Times Cited: 11
Engineering strategies to safely drive CAR T-cells into the future
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Current advancements in cellular immunotherapy for autoimmune disease
Corbett T. Berry, C. Pritchett Frazee, Patrick J. Herman, et al.
Seminars in Immunopathology (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 1
Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications
Alexander Chan, Andrew Tsourkas
BME Frontiers (2023) Vol. 5
Open Access | Times Cited: 20
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
Mohamed Abou‐El‐Enein
Blood Cancer Discovery (2024) Vol. 5, Iss. 4, pp. 249-257
Closed Access | Times Cited: 8
Steering the course of CAR T cell therapy with lipid nanoparticles
Muhammad Babar Khawar, Ali Afzal, Yue Si, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies
Zhaozhao Chen, Yu Hu, Heng Mei
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 16
Metabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
Dan Cappabianca, Dan L. Pham, Matthew H. Forsberg, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101249-101249
Open Access | Times Cited: 6
Metabolic priming of GD2TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
Dan Cappabianca, Dan L. Pham, Matthew H. Forsberg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
Giulia Agliardi, Juliana Dias, Alexandros Rampotas, et al.
The Lancet Haematology (2024)
Closed Access | Times Cited: 4
Stipulations of cell and gene therapy and the ties to biomanufacturing
Justin Allisha, J.J. Das, Thomas Dunnigan, et al.
Biotechnology Progress (2025)
Closed Access
CAR T-cell Therapy Landscape in Pediatric, Adolescent and Young Adult Oncology - A Comprehensive Analysis of Clinical Trials
David A Martínez-Gamboa, Rhea Hans, Eider Moreno-Cortes, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104648-104648
Closed Access
Allogeneic chimeric antigen receptors (CARs) as an “off-the-shelf” therapy in multiple myeloma
Sophie G. Carlson, Tasha Lin, Sarah Larson
Immunotherapy (2025), pp. 1-12
Open Access
Efficient Nonviral Integration of Large Transgenes into Human T Cells Using Cas9-CLIPT
Anna Tommasi, Dan Cappabianca, Madison Bugel, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101437-101437
Open Access
Adoptive T-Cell Therapy in Melanoma
Robert C. Chick, Joal D. Beane, Carlo M. Contreras
Surgical Oncology Clinics of North America (2025)
Closed Access
New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK
Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Immune mediated inflammatory diseases: moving from targeted biologic therapy, stem cell therapy to targeted cell therapy
Zhihou Liang, Hui Xie, Dongze Wu
Frontiers in Immunology (2025) Vol. 16
Open Access
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
Sara Sadat Aghamiri, Rada Amin
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 321-321
Open Access
Page 1 - Next Page

Scroll to top